Evidence map›Paper›PMID 36029296›Full record

ArticleAmerican journal of respiratory and critical care medicine2023

Reply to Nie

Michael C Peters, Mark L Schiebler, David T Mauger, John V Fahy

Open access · hybridAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Michael C PetersUniversity of California, San Francisco San Francisco, California.
Mark L SchieblerUniversity of Wisconsin Madison, Wisconsin.ORCID 0000-0002-9120-5428
David T MaugerThe Pennsylvania State University Hershey, Pennsylvania.
John V FahyUniversity of California, San Francisco San Francisco, California.
University of California, San Francisco · USPennsylvania State University · USUniversity of Wisconsin–Madison · US

Funding

Role of miRNAs in Th2-Driven inflammation in AsthmaP01HL107202 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOCKSLEY, RICHARD M · 2012 to 2023
$23.3M
Protein carbohydrate interactions in the pathophysiology of asthma exacerbationsR01HL080414 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI John V Fahy · 2005 to 2026
$9.2M
Clinical and Molecular Phenotypes of Severe AsthmaU10HL109146 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FAHY, JOHN V · 2011 to 2016
$4.0M
Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and PhysiologyR01HL164787 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FAHY, JOHN V · 2022 to 2025
$2.6M
NHLBI NIH HHS P01 HL107202NHLBI NIH HHS R01 HL080414NHLBI NIH HHS R01 HL164787NHLBI NIH HHS U10 HL109146
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36029296
PMCPMC9952864
OpenAlexW4293331986

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.